DLK2 antibody (C-Term)
Quick Overview for DLK2 antibody (C-Term) (ABIN2783902)
Target
See all DLK2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Sequence
- LVLPAPEPAS VGTPQMPTSA VVVPATGPAP HSAGAGLLRI SVKEVVRRQE
-
Predicted Reactivity
- Cow: 93%, Dog: 86%, Guinea Pig: 86%, Horse: 86%, Human: 100%, Mouse: 100%, Pig: 93%, Rabbit: 93%, Rat: 93%
-
Characteristics
- This is a rabbit polyclonal antibody against Dlk2. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C-terminal region of Mouse Dlk2
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 425 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice." in: Oncoimmunology, Vol. 6, Issue 3, pp. e1290035, (2017) (PubMed).
: "
-
Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice." in: Oncoimmunology, Vol. 6, Issue 3, pp. e1290035, (2017) (PubMed).
-
-